INTRAHEPATIC CHOLANGIOCARCINOMAS ASSOCIATED WITH NONBILIARY CIRRHOSIS - A CLINICOPATHOLOGICAL STUDY

被引:14
作者
TERADA, T
KIDA, T
NAKANUMA, Y
KURUMAYA, H
DOISHITA, K
TAKAYANAGI, N
机构
[1] ISHIKAWA PREFECTURAL HOSP,DEPT PATHOL,KANAZAWA,ISHIKAWA,JAPAN
[2] FUKUI PREFECTURAL HOSP,FUKUI,JAPAN
[3] TOYAMA CITY HOSP,DEPT PATHOL,TOYAMA,JAPAN
关键词
CHOLANGIOCARCINOMA; CIRRHOSIS; CLINICOPATHOLOGY; HISTOCHEMISTRY;
D O I
10.1097/00004836-199406000-00016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To determine the prevalence and clinicopathologic features of cholangiocarcinoma (CC) associated with nonbiliary cirrhosis, we performed a clinicopathologic study. Among the 5,563 autopsies in our laboratories during the past 14 years, 85 (1.5%) were CCs. Four (4.7%) were associated with cirrhosis, due to hepatitis B virus in one case and cryptogenic (probably non-A non-B hepatitis virus) in the remaining three. Clinically, patients with CC and cirrhosis were characterized by male preponderance, lower age, past history of liver injury, and elevated values of zinc sulfate and thymol turbidity tests. Pathologically, all CCs with cirrhosis were basically adenocarcinoma; other histologic features included adenocarcinoma resembling bile ductules without mucin (one case), adenocarcinoma with broad areas of signet ring cell carcinoma (one case), adenocarcinoma with extensive sarcomatoid transformation (one case), and adenocarcinoma associated with hepatoliths (one case). Immunohistochemically, immunophenotypes of carcinoma cells of CC with cirrhosis were not different from those of CC without cirrhosis. Carcinoembryonic antigens, CA19-9, DU-PAN-2, and biliary-type cytokeratins were positive and alpha-fetoprotein was negative, suggesting that our CCs are not hepatocellular neoplasms but true CCs. It must be stressed that there are actual CCs arising in nonbiliary cirrhotic livers.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 46 条
  • [1] BELAMARIC J, 1972, CANCER, V31, P468
  • [2] CONGENITAL DISEASES OF INTRAHEPATIC BILE-DUCTS - VARIATIONS ON THE THEME DUCTAL PLATE MALFORMATION
    DESMET, VJ
    [J]. HEPATOLOGY, 1992, 16 (04) : 1069 - 1083
  • [3] Eggel H, 1901, BEITR PATHOL ANAT AL, V30, P506
  • [4] FALCHUK KR, 1976, AM J GASTROENTEROL, V66, P57
  • [5] FERLANMAROLT V, 1986, CANCER DETECT PREV, V9, P491
  • [6] GANJEI P, 1988, CANCER-AM CANCER SOC, V62, P1994, DOI 10.1002/1097-0142(19881101)62:9<1994::AID-CNCR2820620920>3.0.CO
  • [7] 2-0
  • [8] HARATAKE J, 1991, CANCER, V68, P93, DOI 10.1002/1097-0142(19910701)68:1<93::AID-CNCR2820680119>3.0.CO
  • [9] 2-G
  • [10] HARATAKE J, 1992, CANCER, V69, P2444, DOI 10.1002/1097-0142(19920515)69:10<2444::AID-CNCR2820691010>3.0.CO